Metsera falls after Pfizer files a second lawsuit against co and Novo

Metsera

03/11/2025 14:45

** Shares of drug developer Metsera MTSR.O fall 3.1% to $61.13 after Pfizer PFE.N files a second lawsuit against co and Novo Nordisk NOVOb.CO

** Co's shares hit a record high last week following counter-bid from Novo Nordisk after Pfizer already locked in a deal with it valued at about $7.3 bln

** PFE accusesn MTSR of anticompetitive conduct

** PFE says it is taking the action to "enforce and preserve its rights under the merger agreement"

** PFE filed a lawsuit against MTSR on Friday for breaching the agreement, which the drug developer had disagreed with

** PFE received approval from the U.S. Federal Trade Commission on Friday for proposed buyout of MTSR

** MTSR shares have gained more than double after listing in January

 (Reporting by Utkarsh Tushar Hathi)

 ((utkarshtushar.hathi@thomsonreuters.com))